Movement Alert｜Medline Inc Falls 5.15% in Regular Trading, Truist Slashes Target Price as Major Shareholder Selling Persists

Market Focus08-07

On August 6, Medline Inc fell 5.15% in regular trading, trading at $34.765/share, with turnover of $212 million.

On the news front, Truist Securities significantly cut its price target on Medline from $56 to $47 while maintaining a Buy rating. The current FactSet consensus mean target stands at $47.50. The downgrade came one day after the company reported Q2 results that beat expectations, with adjusted EPS of $0.50 versus the $0.32 consensus and revenue of $7.685 billion topping the $7.512 billion estimate.

Despite the strong earnings beat, sustained selling pressure from major shareholders continues to weigh on the stock. Blackstone, Hellman & Friedman, and Abu Dhabi Investment Authority affiliates have collectively sold over 147 million shares through multiple secondary offerings this year, including 75 million shares in March and 72.6 million shares in May. This persistent supply overhang, combined with ongoing FDA compliance risks following warning letters regarding CGMP violations at the company's Illinois facility, has kept the stock under pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192836670?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 03:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192836670","market":"us","top_or_hot":-1,"title":"Movement Alert｜Medline Inc Falls 5.15% in Regular Trading, Truist Slashes Target Price as Major Shareholder Selling Persists","media":"Market Focus","content":"<p><p>On August 6, Medline Inc fell 5.15% in regular trading, trading at $34.765/share, with turnover of $212 million.</p><p>On the news front, Truist Securities significantly cut its price target on Medline from $56 to $47 while maintaining a Buy rating. The current FactSet consensus mean target stands at $47.50. The downgrade came one day after the company reported Q2 results that beat expectations, with adjusted EPS of $0.50 versus the $0.32 consensus and revenue of $7.685 billion topping the $7.512 billion estimate.</p><p>Despite the strong earnings beat, sustained selling pressure from major shareholders continues to weigh on the stock. Blackstone, Hellman & Friedman, and Abu Dhabi Investment Authority affiliates have collectively sold over 147 million shares through multiple secondary offerings this year, including 75 million shares in March and 72.6 million shares in May. This persistent supply overhang, combined with ongoing FDA compliance risks following warning letters regarding CGMP violations at the company's Illinois facility, has kept the stock under pressure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Medline Inc Falls 5.15% in Regular Trading, Truist Slashes Target Price as Major Shareholder Selling Persists</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Medline Inc Falls 5.15% in Regular Trading, Truist Slashes Target Price as Major Shareholder Selling Persists\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-07 03:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 6, Medline Inc fell 5.15% in regular trading, trading at $34.765/share, with turnover of $212 million.</p><p>On the news front, Truist Securities significantly cut its price target on Medline from $56 to $47 while maintaining a Buy rating. The current FactSet consensus mean target stands at $47.50. The downgrade came one day after the company reported Q2 results that beat expectations, with adjusted EPS of $0.50 versus the $0.32 consensus and revenue of $7.685 billion topping the $7.512 billion estimate.</p><p>Despite the strong earnings beat, sustained selling pressure from major shareholders continues to weigh on the stock. Blackstone, Hellman & Friedman, and Abu Dhabi Investment Authority affiliates have collectively sold over 147 million shares through multiple secondary offerings this year, including 75 million shares in March and 72.6 million shares in May. This persistent supply overhang, combined with ongoing FDA compliance risks following warning letters regarding CGMP violations at the company's Illinois facility, has kept the stock under pressure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDLN","symbol_name":"Medline Inc","start_time":0,"source_url":"","article_id":"1192836670","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192836670","pubTimestamp":1786044872,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 6, Medline Inc fell 5.15% in regular trading, trading at $34.765/share, with turnover of $212 million.On the news front, Truist Securities significantly cut its price target on Medline from...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDLN":"Medline Inc"},"translate_title":"走势警报|Medline Inc 常规交易中下跌 5.15%，Truist 大幅下调目标价，主要股东持续抛售","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDLN":1},"content_text":"On August 6, Medline Inc fell 5.15% in regular trading, trading at $34.765/share, with turnover of $212 million.On the news front, Truist Securities significantly cut its price target on Medline from $56 to $47 while maintaining a Buy rating. The current FactSet consensus mean target stands at $47.50. The downgrade came one day after the company reported Q2 results that beat expectations, with adjusted EPS of $0.50 versus the $0.32 consensus and revenue of $7.685 billion topping the $7.512 billion estimate.Despite the strong earnings beat, sustained selling pressure from major shareholders continues to weigh on the stock. Blackstone, Hellman & Friedman, and Abu Dhabi Investment Authority affiliates have collectively sold over 147 million shares through multiple secondary offerings this year, including 75 million shares in March and 72.6 million shares in May. This persistent supply overhang, combined with ongoing FDA compliance risks following warning letters regarding CGMP violations at the company's Illinois facility, has kept the stock under pressure.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192836670","isCrawlerRequest":true}